Anxiety can take hold in ways that ordinary language struggles to capture — a relentless hum of dread that follows you from waking through every hour of the day, long after the rational part of your mind knows the danger is not real. The National Institute of Mental Health estimates that 19.1% of U.S. adults experience an anxiety disorder in a given year, making anxiety disorders one of the most common categories of mental health conditions nationwide (National Institute of Mental Health, n.d.). If you have tried multiple treatments without finding lasting relief, you are far from alone — and a new class of intervention is now available closer to home than you may realize.
Why Standard Anxiety Treatments Sometimes Fall Short
For many people managing anxiety in Middletown Township, the first-line path is familiar: a selective serotonin reuptake inhibitor, perhaps combined with therapy, and patience measured in weeks. That approach works well for a meaningful portion of patients. But for a substantial number, SSRIs and SNRIs deliver only partial relief, carry side effects that are difficult to tolerate, or gradually lose effectiveness over time. Benzodiazepines, while fast-acting, carry dependence risks that make them unsuitable for long-term anxiety management. Cognitive behavioral therapy remains highly effective, yet access can be limited and progress gradual for those with severe symptoms.
The result is a population of people who are doing everything right — attending appointments, filling prescriptions, practicing the coping skills they were taught — and still finding daily life shaped by anxiety that never quite quiets. If this sounds familiar, our article on treatment-resistant anxiety may help you think through what has already been tried and what questions to ask next. Discuss with your provider whether your current treatment plan is meeting your needs, and ask whether newer interventional options might be worth evaluating.
How Ketamine Works Differently for Anxiety
Ketamine acts on the brain’s glutamate system rather than the serotonin pathways targeted by most conventional psychiatric medications. Specifically, it blocks NMDA receptors and appears to influence downstream pathways involved in brain-derived neurotrophic factor (BDNF) and synaptic plasticity — processes researchers continue to study in relation to rapid symptom change (Deyama & Duman, 2020; Tully et al., 2022). In areas of the brain associated with fear memory and threat processing, including the amygdala and prefrontal cortex, these effects may help interrupt the deeply ingrained patterns that sustain chronic anxiety.
A growing body of research supports ketamine’s potential in anxiety disorders. A systematic review and meta-analysis of randomized controlled trials found that acute ketamine may have broad effects across treatment-resistant anxiety spectrum disorders, while emphasizing that evidence remains preliminary and longer-term protocols need more study (Whittaker et al., 2021). While ketamine’s use for anxiety is considered off-label — meaning it has not been FDA-approved specifically for that indication — many patients with treatment-resistant anxiety have found meaningful relief through medically supervised infusions. To understand more about the mechanisms involved, see our overview of the calming effects of ketamine for anxiety relief. Results vary by individual, and a thorough evaluation is essential before beginning any ketamine protocol.
What IV Ketamine Therapy Involves
At Allevate Health in Middletown Township, IV ketamine therapy is administered directly into the bloodstream, allowing for precise dosing and rapid onset. Each infusion session is conducted in a medically supervised setting with vital-sign monitoring and clinical support throughout the session. A standard initial protocol for depression, anxiety, and PTSD typically involves a series of infusions over two to four weeks.
Before your first infusion: A complimentary consultation allows our team to review your full psychiatric and medical history, current medications, and treatment goals. Not every patient is a candidate — active psychosis, uncontrolled cardiovascular conditions, and certain substance use histories require careful evaluation. Your safety guides every decision.
During the infusion: You will rest comfortably in a private room. Many patients notice mild perceptual shifts — a gentle sense of detachment or dreamlike quality — that resolve as the session ends. These dissociative effects are transient and managed closely by our clinical team.
After the session: You will remain in our care until you are fully oriented and ready to be escorted home. We recommend bringing a trusted person to drive you. Integration support and follow-up care are part of the plan we build with you.
Barriers to Care Worth Acknowledging
Cost and insurance coverage represent a real consideration for many patients in Middletown Township and throughout Monmouth County. IV ketamine for psychiatric indications is not consistently covered by insurance, as it is classified as an off-label use. At Allevate Health, we discuss financial details transparently during your consultation so you can make an informed decision, and our pricing page provides additional information about ketamine infusion costs.
Uncertainty about whether ketamine is right for you is equally valid. Many patients have spent years feeling let down by treatments that promised more than they delivered, and it makes sense to approach something new with measured expectations. Our physicians are here to answer your questions honestly — including the ones about what ketamine cannot do.
Who May Be a Good Candidate
Ketamine for anxiety is most often considered for patients who meet several criteria: prior trials of conventional anxiety medications without adequate relief, a diagnosis of generalized anxiety disorder, social anxiety disorder, or co-occurring anxiety and depression, and absence of the contraindications described above. Patients currently working with a therapist often find that the period after ketamine infusions — when the brain may be more receptive to change — can support deeper progress in their therapy work.
Our team coordinates with referring providers and can communicate directly with your mental health clinician to ensure continuity of care. We will review your treatment history, current symptoms, medications, and goals before recommending any treatment plan.
Taking the First Step in Middletown Township
If anxiety has shaped your daily life for months or years despite consistent effort to treat it, a conversation about ketamine therapy may be one of the most important steps you take this year. Our Middletown Township location at 1270 NJ-35 #4 is built around patients who have not found sufficient relief through standard pathways. Call us at 848-345-5831 or schedule a consultation to speak with our team and learn more about whether ketamine therapy is right for you.
Frequently Asked Questions
Is ketamine for anxiety FDA-approved?
Ketamine’s use for anxiety is considered off-label. Ketamine injection is FDA-approved as an anesthetic, while anxiety is not an FDA-approved indication for ketamine (DailyMed, n.d.). SPRAVATO® is FDA-approved for treatment-resistant depression and depressive symptoms in adults with MDD with acute suicidal ideation or behavior, but IV ketamine for anxiety disorders is used based on clinical evidence and physician judgment outside of formal FDA-approved indications (U.S. Food and Drug Administration, 2025). Learn about SPRAVATO® treatment at Allevate Health.
How quickly might I notice changes in my anxiety?
Some patients report a noticeable shift in anxiety levels within hours of an infusion; others experience more gradual improvement across a series of sessions. A randomized crossover trial in social anxiety disorder found symptom reductions after ketamine compared with placebo, but individual responses vary and research remains ongoing (Taylor et al., 2018). We discuss realistic expectations during your consultation before any treatment begins.
How many infusions are typically involved?
Initial ketamine protocols for anxiety commonly involve a series of infusions administered over several weeks. Maintenance infusions may be recommended on an individual basis depending on your response and ongoing needs.
Will ketamine replace my current anxiety medications?
Not necessarily. Many patients continue other medications alongside ketamine under their provider’s supervision. We coordinate with your existing treatment team to support a safe and integrated approach. Discuss any medication changes only with your licensed provider.
What makes our approach different?
At Allevate Health, every patient receives a thorough evaluation, a complimentary consultation, and a customized treatment plan — not a one-size-fits-all protocol. We focus on medically supervised, evidence-informed care for people who have not found enough relief through standard treatment pathways.
Key Takeaways
Anxiety disorders affect roughly 1 in 5 American adults each year, and many patients do not find adequate relief through standard treatments alone (National Institute of Mental Health, n.d.).
Ketamine acts on the brain’s glutamate system, offering a mechanism distinct from conventional anxiety medications.
IV ketamine for anxiety is an off-label treatment supported by emerging evidence; results vary by individual and a thorough evaluation is required.
At our Middletown Township location, we offer ketamine therapy in a medically supervised setting with a complimentary consultation.
Financial considerations and individual suitability are discussed openly during consultation so you can make an informed decision.
References
Deyama, S., & Duman, R. S. (2020). Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine. Pharmacology Biochemistry and Behavior, 188, 172837. https://doi.org/10.1016/j.pbb.2019.172837
National Institute of Mental Health. (n.d.). Any anxiety disorder. https://www.nimh.nih.gov/health/statistics/any-anxiety-disorder
Taylor, J. H., Landeros-Weisenberger, A., Coughlin, C., Mulqueen, J., Johnson, J. A., Gabriel, D., Reed, M. O., Jakubovski, E., & Bloch, M. H. (2018). Ketamine for social anxiety disorder: A randomized, placebo-controlled crossover trial. Neuropsychopharmacology, 43(2), 325–333. https://doi.org/10.1038/npp.2017.194
Tully, J. L., Dahlén, A. D., Haggarty, C. J., Schiöth, H. B., & Brooks, S. (2022). Ketamine treatment for refractory anxiety: A systematic review. British Journal of Clinical Pharmacology, 88(10), 4412–4426. https://doi.org/10.1111/bcp.15374
U.S. Food and Drug Administration. (2025). SPRAVATO® (esketamine) nasal spray, CIII prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211243s016lbl.pdf
Whittaker, E., Dadabayev, A. R., Joshi, S. A., & Glue, P. (2021). Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders. Therapeutic Advances in Psychopharmacology, 11, 20451253211056743. https://doi.org/10.1177/20451253211056743
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine therapy and SPRAVATO® should only be pursued under the supervision of a licensed provider familiar with your full medical and psychiatric history. Individual results vary. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.